Oncternal Therapeutics Inc. (ONCT) Tops Q4 EPS by 1c

Oncternal Therapeutics Inc. (NASDAQ: ONCT) reported Q4 EPS of ($0.20), $0.01 better than the analyst estimate of ($0.21). Revenue for the quarter came in at $171 thousand versus the consensus estimate of $306.2 thousand.

For earnings history and earnings-related data on Oncternal Therapeutics Inc. (ONCT) click here.

You May Also Be Interested In

• Etsy upgraded to buy at BofA on durable growth, buyback potential
• Walmart (WMT) Tops Q2 EPS by 7c, Beats on Revenue; Offers FY27 EPS Guidance
• Advance Auto Parts falls on revenue miss, weak guidance